Combinatorial CAR design improves target restriction

CAR T cells targeting the B lymphocyte antigen CD19 have led to remarkable clinical results in B cell leukemia and lymphoma but eliminate all B lineage cells, leading to increased susceptibility to severe infections. As malignant B cells will express either immunoglobulin (Ig) light chain κ or λ, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Köksal, Hakan, Dillard, Pierre, Juzeniene, Asta, Kvalheim, Gunnar, Smeland, Erlend B., Myklebust, June H., Inderberg, Else Marit, Wälchli, Sébastien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948400/
https://www.ncbi.nlm.nih.gov/pubmed/33234592
http://dx.doi.org/10.1074/jbc.RA120.016234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948400/
https://www.ncbi.nlm.nih.gov/pubmed/33234592
http://dx.doi.org/10.1074/jbc.RA120.016234

Ejemplares similares